CREO

Creo Medical Group
CREO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£53.33M
EV
£49.03M
Shares Outstanding
402.47M
Beta
0.54

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£0.71
P/E 2025E
-
P/Revenue 2025E
8.74x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Creo Medical Group PLC

gainify
CREO

Creo Medical Group PLC

CREO

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localize...

Sector

Healthcare

Industry

Medical - Devices

CEO

Gulliford, Craig

Employees

129

IPO Date

2016-12-09

Headquarters

Creo House, Unit 2, Beaufort Park, Beaufort Park Way, Chepstow, Gwent, NP16 5UH, United Kingdom

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.